-Andrew D Hamilton Researcher Activity Profile

Research Author Detailed Information 

Andrew D Hamilton Publication Rate By Year

Andrew D Hamilton has published 1 paper(s) in 2002, 1 paper(s) in 2003, 2 paper(s) in 2004, 4 paper(s) in 2006, 17 paper(s) in 2007, for a total of 25 research publications in total.

Andrew D Ad Hamilton Author Information

LAST NAME: hamilton

FIRST NAME: Andrew D

INITIALS: ad

AFFILIATION:

Papers

Andrew D Hamilton's Publication Record

1. Diphenylindane-based proteomimetics reproduce the projection of the i, i+3, i+4, and i+7 residues on an alpha-helix. Year Published: 2006
Department of Chemistry, Yale University, P.O. Box 20810, New Haven, Connecticut 06511, USA.
2. Synthesis and evaluation of potent, highly-selective, 3-aryl-piperazinone inhibitors of protein geranylgeranyltransferase-I. Year Published: 2006
Department of Chemistry, Yale University, New Haven, CT 06520, USA.
3. Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation. Year Published: 2006
Department of Chemistry, Yale University, New Haven, CT 06520, USA.
4. Recognition of solvent exposed protein surfaces using anthracene derived receptors. Year Published: 2007
Department of Chemistry, PO Box 208107, 225 Prospect Street, Yale University, New Haven, CT 06520-8107, USA.
5. Synthetic non-peptide mimetics of alpha-helices. Year Published: 2007
Department of Chemistry, Fairfield University, Fairfield, CT 06824, USA. jmdavis@mail.fairfield.edu
6. Modifications of the GSK3beta substrate sequence to produce substrate-mimetic inhibitors of Akt as potential anti-cancer therapeutics. Year Published: 2007
Department of Chemistry, Yale University, PO Box 208107, New Haven, CT 06520, USA.
7. Protein-protein interaction inhibitors: small molecules from screening techniques. Year Published: 2007
Department of Chemistry, Yale University, P.O. Box 208107, New Haven, CT 06520-8107, USA.
8. Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. Year Published: 2007
Department of Chemistry, Yale University, P. O. Box 208107, New Haven, CT 06520-8107, USA.
9. Solvent and pH effects on the fluorescence of 7-(dimethylamino)-2-fluorenesulfonate. Year Published: 2007
Department of Chemistry, Yale University, New Haven, CT 06520-8107, USA.
10. Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase. Year Published: 2007
Department of Medicine, University of Washington, Room I-104-E, Health Sciences Building, Seattle, WA 98195-7185, USA. wesley@u.washington.edu
11. Allosteric control of self-assembly: modulating the formation of guanine quadruplexes through orthogonal aromatic interactions. Year Published: 2007
Department of Chemistry, Yale University, P. O. Box 208107, New Haven, CT 06520-8107, USA.
12. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth. Year Published: 2007
Drug Discovery Program, The H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
13. Allosteric control of self-assembly: modulating the formation of guanine quadruplexes through orthogonal aromatic interactions. Year Published: 2007
Department of Chemistry, Yale University, P. O. Box 208107, New Haven, CT 06520-8107, USA.
14. Benzoylurea oligomers: synthetic foldamers that mimic extended alpha helices. Year Published: 2007
Department of Chemistry, Yale University, 225 Prospect Street, P.O. Box 208107, New Haven, CT 06520-8107, USA.
15. Benzoylurea oligomers: synthetic foldamers that mimic extended alpha helices. Year Published: 2007
Department of Chemistry, Yale University, 225 Prospect Street, P.O. Box 208107, New Haven, CT 06520-8107, USA.
16. An oxazole-based small-molecule stat3 inhibitor modulates stat3 stability and processing and induces antitumor cell effects. Year Published: 2007
Department of Molecular Biology and Microbiology, University of Central Florida College of Medicine, Orlando, Florida 32826 BioMolecular Science Center and jturkson@mail.ucf.edu.
17. An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects. Year Published: 2007
BioMolecular Science Center, Department of Molecular Biology and Microbiology, University of Central Florida College of Medicine, Orlando, Florida 32826, USA.
18. Benzoylurea oligomers: synthetic foldamers that mimic extended alpha helices. Year Published: 2007
Department of Chemistry, Yale University, 225 Prospect Street, P.O. Box 208107, New Haven, CT 06520-8107, USA.
19. Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry. Year Published: 2002
Department of Chemistry, Yale University, P.O. Box 208107, New Haven, CT 06520-8107, USA.
20. Directed denaturation: room temperature and stoichiometric unfolding of cytochrome C by a metalloporphyrin dimer. Year Published: 2003
Department of Chemistry, P.O. Box 208107, 225 Prospect Street, Yale University, New Haven, CT 06520-8107, USA.
21. Design of a synthetic foldamer that modifies the growth of calcite crystals. Year Published: 2004
Yale University, Department of Chemistry, New Haven, Connecticut 06520-8107, USA.
22. Pattern-based detection of different proteins using an array of fluorescent protein surface receptors. Year Published: 2004
Department of Chemistry, Yale University, P.O. Box 208107, 225 Prospect Street, New Haven, Connecticut 06520-8107, USA.
23. FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase. Year Published: 2006
Department of Chemistry, Yale University, New Haven, Connecticut 06520-8107, USA.
24. An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects. Year Published: 2007
BioMolecular Science Center, Department of Molecular Biology and Microbiology, University of Central Florida College of Medicine, Orlando, Florida 32826, USA.
25. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth. Year Published: 2007
Drug Discovery Program, The H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.